相关实验视频

Updated: Jul 20, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

PEGylated纳米粒子与血液免疫系统之间的相互作用

Chen Guo¹, Haoyang Yuan¹, Yuxiu Wang¹

¹Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.

Advanced drug delivery reviews

|August 4, 2023

概括

聚乙烯甘醇 (PEG) 免疫性可以导致PEG化纳米颗粒的加速血液清理 (ABC) 和过敏反应 (HSR). 了解这些免疫反应对于开发更安全的纳米粒子配方至关重要.

科学领域:

生物材料科学生物材料科学
免疫学免疫学免疫学
纳米技术纳米技术

背景情况:

聚乙烯糖醇 (PEG) 对纳米颗粒的修饰是常见的,但可以引起免疫反应.
对PEGylated纳米颗粒的加速血液清理 (ABC) 和过敏反应 (HSR) 限制了它们的治疗效果,并带来了安全风险.
发表文献中的不同结果强调需要更清楚地了解PEG免疫性.

研究的目的:

阐明PEG特异性免疫反应背后的生理机制.
解释关于PEGylated纳米颗粒和免疫反应的矛盾发现.
讨论纳米粒子相关因素对免疫反应的影响.

主要方法:

对关于PEG免疫性,ABC和HSR的现有文献的审查.
对PEG特异性免疫反应的生理机制的分析.
关于免疫反应的诱导和执行阶段之间的关系的猜测.
基于作用阶段的纳米粒子相关因素的分类.

主要成果:

总结了PEG特异性免疫反应的生理机制.
提出了一个框架来解释有关PEGylated纳米颗粒的不同结果.
讨论了影响免疫反应的纳米粒子因素.

结论:

更深入地了解PEG免疫性机制对于设计更安全的PEG化纳米颗粒至关重要.
解决PEG特异性免疫反应可以提高纳米粒子的有效性和患者的安全性.
本综述为开发策略提供了见解,以减轻对PEGylated纳米材料的不良免疫反应.

关键词:

这是ABC现象.产生抗体的方法补充激活的激活方式过敏症是一种过敏症.带有PEG的纳米颗粒.

更多相关视频

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

相关概念视频

Drug Binding to Blood Components

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...

Factors Affecting Protein-Drug Binding: Drug Interactions

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...